Gemcitabine and atrial fibrillation: A rare manifestation of chemotherapy toxicity

Anti-Cancer Drugs

Volumn 17, Issue 3, 2006, Pages 359-361

  Ferrari, Daris ^a   Carbone, Claudia ^a   Codecà, Carla ^a   Fumagalli, Luca ^a   Gilardi, Laura ^a   Marussi, Desiré ^a   Tartaro, Tiziana ^a   Oldani, Sabina ^a   Zannier, Francesca ^a   Foa, Paolo ^a  

^a SAN PAOLO HOSPITAL   (Italy)

Author keywords

Atrial fibrilation; Cardiac toxicity; Gemcitabine

Indexed keywords

2',2' DIFLUORODEOXYURIDINE; AMIODARONE; DIGITALIS GLYCOSIDE; DOCETAXEL; DRUG METABOLITE; GEMCITABINE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CASE REPORT; COLON CANCER; DOSE TIME EFFECT RELATION; DRUG INFUSION; DYSPNEA; FEMALE; HEAD AND NECK CANCER; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HEART RATE; HEART RHYTHM; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG METASTASIS; MANDIBLE CANCER; PANCREAS CANCER; PRIORITY JOURNAL; RARE DISEASE; RISK FACTOR; UROGENITAL TRACT CANCER;

AGED; ATRIAL FIBRILLATION; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS;

EID: 33646095485     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200603000-00016     Document Type: Article

References (16)

1. Santini D, Tonini G, Abbate A, Di Cosimo S, Gravante G, Vincenti B, et al. Gemcitabine-induced atrial fibrillation: a hitherto unreported manifestation of drug toxicity. Ann Oncol 2000; 11:479-481.
2. Plunkett W, Huang P, Xu YZ, Heinemann V, Grunewald R, Ghandi V. Gemcitabine: metabolism, mechanisms of action and self-potentiation. Semin Oncol 1995; 32:3-10.
3. Plunkett W, Huang P, Gandhi V. Preclinical characteristics of gemcitabine. Anticancer Drugs 1995; 6(Suppl 6):7-13.
4. Gianni L, Sessa C, Capri G, Grasselli G, Bianchi G, Vitali G. Farmaci chemioterapici. In: Bonadonna G, Robustelli Della Cuna G, Valagussa P (editors): Medicina oncologica 7. Milan: Masson; 2003. pp. 631-632.
5. Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, et al. A phase I clinical, plasma and cellular pharmacology study of gemcitabine. J Clin Oncol 1991; 9:491-498.
6. Davidoff S, Shah RD, Arunabh T. Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR). Respir Med 2005. (Epub ahead of print)
7. Pavlakis N, Bell DR, Millward MJ, Levi JA. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 1997; 80:286-291.
8. Storniolo AM, Allerheiligen SR, Pearche HL. Preclinical, pharmacologic, and phase I studies of gemcitabine. Semin Oncol 1997; 24 (Suppl 2): S7-2-S7-7.
9. Machover D, Goldschmit E, Chollet P, Metzger G, Zittoun J, Marquet J, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 1985; 4:685-696.
10. Narayan SM, Cain ME, Smith JM. Atrial fibrillation [seminar]. Lancet 1997; 350:943-950.
11. Gridelli C, Cigolari S, Gallo C, Manzione L, lanniello GP, Frontini L, et al. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients. Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. Lung Cancer 2001; 31:277-284.
12. Illiano A, Barletta E, De Marino V, Battiloro C, Barzelloni M, Scognamiglio F, et al. New triplet chemotherapy combination with carboplatin, paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer: a phase II study. Anticancer Res 2000; 20:3999-4003.
13. Wood AJJ. Adverse reactions to drug. In: Fauci AS, Braunwald E, Kasper DL, Hanser JL, Longo DL, Jameson JL (editors): Harrison's principles of internal medicine, 14th edn. New York: McGraw-Hill; 1998; pp. 422-430.
14. Petrella V, Alciato P, Cantone PA, Fico D, Gagliardini R. High-frequency supraventricular arrhythmias induced by a cisplatin-etoposide combination. Minerva Med 1989; 80:305-307.
15. Aziz Sa, Tramboo NA, Mohi-ud-Din K, Iqbal K, Jalal S, Ahmad M. Supraventricular arrhythmias: a complication of 5-fluorouracil therapy. Clin Oncol (R Coll Radiol) 1998; 10:377-378.
16. Williams GH, Lilly LS, Seely EW. The heart in endocrine and nutrional disorders. In: Braunwald E (editor): Heart disease, 5th edn. Philadelphia: Saunders; 1995. pp. 1901-1903.